The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-((3',4'-difluorobiphenyl-4-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine ID: ALA1077991
PubChem CID: 46882714
Max Phase: Preclinical
Molecular Formula: C23H21F2NO2S
Molecular Weight: 413.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(Cc1ccc2c(c1)CCNCC2)c1ccc(-c2ccc(F)c(F)c2)cc1
Standard InChI: InChI=1S/C23H21F2NO2S/c24-22-8-5-19(14-23(22)25)17-3-6-21(7-4-17)29(27,28)15-16-1-2-18-9-11-26-12-10-20(18)13-16/h1-8,13-14,26H,9-12,15H2
Standard InChI Key: JYOJZLONKKFYQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
0.0290 -11.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6877 -10.6917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4005 -11.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3957 -11.9353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6801 -12.3409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0329 -11.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7408 -10.6833 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.4616 -8.6187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4604 -9.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1785 -9.8556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1765 -8.2056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6887 -9.0346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3333 -8.2880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5307 -8.1045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3312 -9.7745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5275 -9.9573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8870 -9.4400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8860 -8.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7402 -9.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4495 -10.2654 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1468 -11.3938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1078 -12.3530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8238 -11.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5355 -12.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5303 -13.1842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8074 -13.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0987 -13.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2419 -13.6029 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.2531 -11.9495 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
12 13 1 0
13 14 1 0
12 15 1 0
16 17 1 0
17 18 1 0
18 14 1 0
15 16 1 0
9 10 1 0
9 19 1 0
19 7 1 0
7 1 1 0
10 17 2 0
7 20 2 0
2 3 1 0
7 21 2 0
18 11 2 0
4 22 1 0
11 8 1 0
22 23 2 0
5 6 2 0
23 24 1 0
6 1 1 0
24 25 2 0
1 2 2 0
25 26 1 0
3 4 2 0
26 27 2 0
27 22 1 0
25 28 1 0
8 9 2 0
24 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 413.49Molecular Weight (Monoisotopic): 413.1261AlogP: 4.29#Rotatable Bonds: 4Polar Surface Area: 46.17Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.86CX LogP: 4.51CX LogD: 2.12Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -1.28
References 1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969 ] [10.1016/j.bmcl.2009.09.027 ]